Replies to post #14060 on Todos Med Ltd (TOMDF)

[delerious1]

That is pure misinformation and nonsense

In order to raise funds you have to give something for that, unless you're asking for charity. So raising funds will cause dilution of value in some way...it has to.

Giving away part of 3CL Pharma to raise funding dilutes TOMDF value...pretty simple

TANSTAAFL

[Gainzzz]

ProVista was always supposed to be the funder for everything Tollo (Tollovid, Tollovir, TolloTest). Go back and listen to every webcast GC did between Feb 21' - May 22'. Provista was always aimed to be the "Business" & "Funder" of Todos research. GC sold this vision to shareholders to acquire ProVista from Rob Rill (do your dd on him for a good laugh on who GC likes to get in bed with). The only reason 3CL Pharma was ever needed in the first place is because we have a class A moron steering this ship and has single handedly failed in getting any real traction and revenue at ProVista. He literally said in the last investor meeting ProVista revenue was down because their largest revenue producer (1 freaking k-12 school district) quit testing. I repeat, for all the gibberish GC talks of expanded testing solutions (HIV, Wound, MonkeyPox...etc), expanded testing capacity (50k a day now), lab and physician reference contracts, and on and on and on, he has 1 freaking revenue driving client. I find it pretty hilarious how many investors are giddy with joy over the 3CL crowdfunding and kickoff. Sorry I don't find losing 40% value to another GC BS spinoff exciting. GC's laziness around everything Provista got us to this God awful point. Don't ever forget that. 3CL Parma is a middle finger to shareholders.

[Rotten Johnny]

easy to answer

TOMDF raises fiunds on their preapproved 10-BIL AUTHORIZED SHARES



JMHO